Early Detection of Multiple Resistance Mechanisms by ctDNA Profiling in a Patient With EGFR-mutant Lung Adenocarcinoma Treated With Osimertinib

Autor:	Sebastiao N. Martins-Filho, Ming-Sound Tsao, Geoffrey Liu, Hua Bao, J. Law, Adrian G. Sacher, Erin L. Stewart, Xue Wu, S. Schmid, Ao Wang, Scott V. Bratman, Zhuo Chen, Penelope A. Bradbury, Deval Patel, Frances A. Shepherd, Natasha B. Leighl, Michael Cabanero, Trevor J. Pugh
Rok vydání:	2020
Předmět:	Pulmonary and Respiratory Medicine Cancer Research Lung business.industry Mutant Early detection medicine.disease medicine.anatomical_structure Oncology Cancer research Medicine Adenocarcinoma Osimertinib Liquid biopsy business Lung cancer
Zdroj:	Clinical Lung Cancer. 21:e488-e492
ISSN:	1525-7304
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::f305c9877dcea0fb8bdd6a2a9cb44366 https://doi.org/10.1016/j.cllc.2020.03.009 Zobrazit plný text záznamu Full Text from ScienceDirect